Numerai Gp LLC Xeris Biopharma Holdings, Inc. Transaction History
Numerai Gp LLC
- $709 Billion
- Q3 2025
A detailed history of Numerai Gp LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 18,507 shares of XERS stock, worth $134,175. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,507Holding current value
$134,175% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
237Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...